Enteral nutrition should be used to induce remission in childhood Crohn's disease

Digestive Diseases

Volumn 27, Issue 3, 2009, Pages 297-305

  Heuschkel, Robert ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Crohn's disease; Enteral nutrition; Inflammatory bowel disease

Indexed keywords

STEROID; TRANSFORMING GROWTH FACTOR BETA;

CHILD; CONFERENCE PAPER; CROHN DISEASE; ELEMENTAL DIET; ENTERIC FEEDING; HUMAN; INTERMETHOD COMPARISON; INTESTINE MUCOSA; MALNUTRITION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN DIET; REMISSION; STEROID THERAPY;

CHILD; CROHN DISEASE; ENTERAL NUTRITION; HUMANS; REMISSION INDUCTION;

EID: 70349935458     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228564     Document Type: Conference Paper

References (81)

1. Stephens RV, Randall HT: Use of concentrated, balanced, liquid elemental diet for nutritional management of catabolic states. Ann Surg 1969; 170: 642-668.
2. Johnson T, et al: Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 2006; 55: 356-361. (Pubitemid 43268273)
3. Beattie RM, et al: Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 1994; 8: 609-615. (Pubitemid 24381361)
4. Fell JM, et al: Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 2000; 14: 281-289.
5. Ruuska T, et al: Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 1994; 19: 175-180. (Pubitemid 24299626)
6. Seidman E, et al: Semi-elemental diet vs. prednisolone in pediatric Crohn's disease. Gastroenterology 1993; 104: 778.
7. Day AS, et al: Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol 2006; 21: 1609-1614.
8. Lochs H, et al: Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. Part IV. Gastroenterology 1991; 101: 881-888.
9. Malchow H, et al: European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249-266. (Pubitemid 14218578)
10. Afzal NA, et al: Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci 2005; 50: 1471-1475.
11. Lim S, et al: Treatment of orofacial and ileocolonic Crohn's disease with total enteral nutrition. J R Soc Med 1998; 91: 489-490. (Pubitemid 28470043)
12. Afzal NA, et al: Refeeding syndrome with enteral nutrition in children: a case report, literature review and clinical guidelines. Clin Nutr 2002; 21: 515-520.
13. Winitz M, et al: Nature, Volume 205, 1965: Evaluation of chemical diets as nutrition for man-in-space. Nutr Rev 1991; 49: 141-143.
14. Voitk AJ, et al: Experience with elemental diet in the treatment of inflammatory bowel disease: is this primary therapy? Arch Surg 1973; 107: 329-333.
15. Logan RF, et al: Reduction of gastrointestinal protein loss by elemental diet in Crohn's disease of the small bowel. Gut 1981; 22: 383-387.
16. Giorgini GL, Stephens RV, Thayer WR Jr: The use of 'medical by-pass' in the therapy of Crohn's disease: report of a case. Am J Dig Dis 1973; 18: 153-157.
17. Navarro J, et al: Prolonged constant rate elemental enteral nutrition in Crohn's disease. J Pediatr Gastroenterol Nutr 1982; 1: 541-546.
18. Morin CL, et al: Continuous elemental enteral alimentation in children with Crohn's disease and growth failure. Gastroenterology 1980; 79: 1205-1210.
19. O'Morain C: Crohn's disease treated by elemental diet. J R Soc Med 1982; 75: 135-136.
20. Morin CL, et al: Continuous elemental enteral alimentation in the treatment of children and adolescents with Crohn's disease. JPEN J Parenter Enteral Nutr 1982; 6: 194-199.
21. O'Morain C, Segal AW, Levi AJ: Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Ed) 1984; 288: 1859-1862.
22. Sanderson IR, et al: Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 1987; 62: 123-127. (Pubitemid 17004189)
23. Akobeng AK, et al: Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 2000; 30: 78-84. (Pubitemid 30349950)
24. Silk DB, et al: Use of a peptide rather than free amino acid nitrogen source in chemically defined 'elemental' diets. JPEN J Parenter Enteral Nutr 1980; 4: 548-553.
25. Raouf AH, et al: Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge. Gut 1991; 32: 702-707.
26. Gonzalez-Huix F, et al: Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut 1993; 34: 778-782. (Pubitemid 23185103)
27. Beattie RM, Walker-Smith JA: Treatment of active Crohn's disease by exclusion diet. J Pediatr Gastroenterol Nutr 1994; 19: 135-136. (Pubitemid 24243204)
28. Rodrigues AF, et al: Does polymeric formula improve adherence to liquid diet therapy in children with active Crohn's disease? Arch Dis Child 2007; 92: 767-770.
29. Hyams JS, et al: Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991; 12: 439-447.
30. Breese EJ, et al: The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment Pharmacol Ther 1995; 9: 547-552.
31. Bannerjee K, et al: Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004; 38: 270-275.
32. Gassull MA, et al: Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 2002; 51: 164-168.
33. Miura S, et al: Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease. J Gastroenterol Hepatol 1998; 13: 1183-1190. (Pubitemid 29029948)
34. Sakurai T, et al: Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas. JPEN J Parenter Enteral Nutr 2002; 26: 98-103. (Pubitemid 34163552)
35. Leiper K, et al: A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease. Gut 2001; 49: 790-794. (Pubitemid 33096036)
36. von Tirpitz C, et al: Lactose intolerance in active Crohn's disease: clinical value of duodenal lactase analysis. J Clin Gastroenterol 2002; 34: 49-53.
37. Malchow H, et al: Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III. Scand J Gastroenterol 1990; 25: 235-244. (Pubitemid 20194855)
38. Griffiths AM, et al: Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 1995; 108: 1056-1067.
39. Zachos M, Tondeur M, Griffiths AM: Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007;1:CD000542. (Pubitemid 351835440)
40. Modigliani R, et al: Clinical, biological, and endoscopic picture of attacks of Crohn's disease: evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology 1990; 98: 811-818.
41. Zachos M, Tondeur M, Griffiths AM: Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev 2001;3:CD000542.
42. Heuschkel RB: Enteral nutrition in children with Crohn's disease. J Pediatr Gastroenterol Nutr 2000; 31: 575.
43. Dziechciarz P, et al: Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 2007; 26: 795-806. (Pubitemid 47346708)
44. Day AS, et al: Systematic review: nutritional therapy in paediatric Crohn's disease. Aliment Pharmacol Ther 2008; 27: 293-307.
45. Markowitz J, et al: Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol 2006; 4: 1124-1129. (Pubitemid 44311642)
46. Murch SH, Walker-Smith JA: Nutrition in inflammatory bowel disease. Baillieres Clin Gastroenterol 1998; 12:719-738 .
47. Rigaud D, et al: Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut 1991; 32: 1492-1497.
48. Thomas AG, Taylor F, Miller V: Dietary intake and nutritional treatment in childhood Crohn's disease. J Pediatr Gastroenterol Nutr 1993; 17: 75-81. (Pubitemid 23199293)
49. Riordan AM, et al: Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet 1993; 342: 1131-1134. (Pubitemid 23324052)
50. Pearson M, et al: Food intolerance and Crohn's disease. Gut 1993; 34: 783-787.
51. Peac S, et al: Mucosal-associated bacterial flora of the intestine in patients with Crohn's disease and in a control group. Gut 1978; 19: 1034-1042.
52. Axelsson CK, Justesen T: Studies of the duo-denal and fecal flora in gastrointestinal disorders during treatment with an elemental diet. Gastroenterology 1977; 72: 397-401.
53. Lionetti P, et al: Enteral nutrition and microflora in pediatric Crohn's disease. JPEN J Parenter Enteral Nutr 2005; 29(4 suppl): S173-S175; discussion S175-S178, S184-S188.
54. Swidsinski A, et al: Mucosal flora in inflammatory bowel disease. Gastroenterology 2002; 122: 44-54. (Pubitemid 34049193)
55. Rutgeerts P, et al: Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108: 1617-1621.
56. Pourtaghi N, et al: The effect of subgingival antimicrobial therapy on the levels of stromelysin and tissue inhibitor of metalloproteinases in gingival crevicular fluid. J Periodontol 1996; 67: 866-870. (Pubitemid 26322928)
57. Linskens RK, et al: The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl 2001;234:29-40.
58. Kishi D, et al: Alteration of V beta usage and cytokine production of CD4+ TCR beta beta homodimer T cells by elimination of Bacteroides vulgatus prevents colitis in TCR alpha-chain-deficient mice. J Immunol 2000; 165: 5891-5899.
59. Tanaka S, et al: Amelioration of chronic inflammation by ingestion of elemental diet in a rat model of granulomatous enteritis. Dig Dis Sci 1997; 42: 408-419. (Pubitemid 27112991)
60. Tanaka S, et al: Elemental diet reduces progression of chronic inflammation and alters nitric oxide metabolism in a rat model of granulomatous colitis. Gastroenterology 1999 (abstract).
61. Greenberg GR, et al: Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Gut 1988; 29: 1309-1315.
62. Wilschanski M, et al: Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 1996; 38: 543-548. (Pubitemid 26111374)
63. Koster F, Pierce NF: Effect of protein deprivation on immunoregulatory cells in the rat mucosal immune response. Clin Exp Immunol 1985; 60: 217-224. (Pubitemid 15104898)
64. Lamont AG, Gordon M, Ferguson A: Oral tolerance in protein-deprived mice. II. Evidence of normal 'gut processing' of ovalbumin, but suppressor cell deficiency, in deprived mice. Immunology 1987; 61: 339-343.
65. Sanderson IR: Dietary regulation of genes expressed in the developing intestinal epithelium. Am J Clin Nutr 1998; 68: 999-1005.
66. Nishimura A, et al: Short-chain fatty acids regulate IGF-binding protein secretion by intestinal epithelial cells. Am J Physiol 1998; 275:E55-E63. (Pubitemid 28374651)
67. Fusunyan RD, et al: Butyrate enhances interleukin (IL)-8 secretion by intestinal epithelial cells in response to IL-1beta and lipopolysaccharide. Pediatr Res 1998; 43: 84-90.
68. Ohtsuka Y, et al: MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut 2001; 49: 526-533. (Pubitemid 32896983)
69. Kulkarni AB, et al: Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993; 90: 770-774. (Pubitemid 23028947)
70. Akobeng AK, et al: Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn's disease. Clin Nutr 2007; 26: 51-56.
71. Wright NA, et al: Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993; 104: 12-20.
72. Babyatsky MW, et al: Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology 1996; 110: 489-497.
73. Beattie RM, Bentsen BS, MacDonald TT: Childhood Crohn's disease and the efficacy of enteral diets. Nutrition 1998; 14: 345-350. (Pubitemid 28222230)
74. Kirschner BS: Nutritional consequences of inflammatory bowel disease on growth. J Am Coll Nutr 1988; 7: 301-308. (Pubitemid 18207001)
75. Kirschner BS, et al: Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution. Gastroenterology 1981; 80: 10-15.
76. Kirschner BS, Sutton MM: Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 1986; 91: 830-836. (Pubitemid 16014587)
77. Thomas AG, et al: Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut 1993; 34: 944-947.
78. Walker-Smith JA: Mucosal healing in Crohn's disease. Gastroenterology 1998; 114: 419-420.
79. Fell JM, et al: Normalisation of mucosal cytokine mRNA in association with clinical improvement in children with Crohn's disease treated with polymeric diet. J Paediatr Gastroenterol 1998; 26: 544.
80. Berni Canani R, et al: Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease. Dig Liver Dis 2006; 38: 381-387. (Pubitemid 44356207)
81. Munkholm P, et al: Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993; 105: 1716-1723. (Pubitemid 24002788)